▶ 調査レポート

世界の全身性抗生物質市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Systemic Antibiotics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界の全身性抗生物質市場規模・現状・予測(2021年-2027年) / Global Systemic Antibiotics Market Size, Status and Forecast 2021-2027 / QFJ1-4928資料のイメージです。• レポートコード:QFJ1-4928
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、106ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、全身性抗生物質の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他)、用途別市場規模(病院、専門クリニック、在宅医療、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・全身性抗生物質の市場動向
・企業の競争状況、市場シェア
・全身性抗生物質の種類別市場規模と予測2016-2027(βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他)
・全身性抗生物質の用途別市場規模と予測2016-2027(病院、専門クリニック、在宅医療、その他)
・全身性抗生物質の北米市場規模2016-2027(アメリカ、カナダ)
・全身性抗生物質の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・全身性抗生物質のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・全身性抗生物質の中南米市場規模2016-2027(メキシコ、ブラジル)
・全身性抗生物質の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Bausch Health、Teva Pharmaceutical Industries、Dr. Reddy's Laboratories、Sun Pharmaceutical Industries、Amneal Pharmaceuticals、Pfizer、Mylan、Novartis、Hikma Pharmaceuticals、Aurobindo Pharma、Allergan、GlaxoSmithKline)
・結論

It refers to a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants that have anti-pathogens or other activities during their life, and can interfere with the development of other living cells. substance.

Market Analysis and Insights: Global Systemic Antibiotics Market
The global Systemic Antibiotics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Systemic Antibiotics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Systemic Antibiotics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Systemic Antibiotics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Systemic Antibiotics market.

Global Systemic Antibiotics Scope and Market Size
Systemic Antibiotics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
β Lactam & β lactamase Inhibitors
Quinolone
Macrolide
Others

Segment by Application
Hospital
Specialty Clinic
Homecare
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Bausch Health
Teva Pharmaceutical Industries
Dr. Reddy’s Laboratories
Sun Pharmaceutical Industries
Amneal Pharmaceuticals
Pfizer
Mylan
Novartis
Hikma Pharmaceuticals
Aurobindo Pharma
Allergan
GlaxoSmithKline

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Antibiotics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 β Lactam & β lactamase Inhibitors
1.2.3 Quinolone
1.2.4 Macrolide
1.2.5 Others
1.3 Market by Application
1.3.1 Global Systemic Antibiotics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Specialty Clinic
1.3.4 Homecare
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Systemic Antibiotics Market Perspective (2016-2027)
2.2 Systemic Antibiotics Growth Trends by Regions
2.2.1 Systemic Antibiotics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Systemic Antibiotics Historic Market Share by Regions (2016-2021)
2.2.3 Systemic Antibiotics Forecasted Market Size by Regions (2022-2027)
2.3 Systemic Antibiotics Industry Dynamic
2.3.1 Systemic Antibiotics Market Trends
2.3.2 Systemic Antibiotics Market Drivers
2.3.3 Systemic Antibiotics Market Challenges
2.3.4 Systemic Antibiotics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Systemic Antibiotics Players by Revenue
3.1.1 Global Top Systemic Antibiotics Players by Revenue (2016-2021)
3.1.2 Global Systemic Antibiotics Revenue Market Share by Players (2016-2021)
3.2 Global Systemic Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Systemic Antibiotics Revenue
3.4 Global Systemic Antibiotics Market Concentration Ratio
3.4.1 Global Systemic Antibiotics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Antibiotics Revenue in 2020
3.5 Systemic Antibiotics Key Players Head office and Area Served
3.6 Key Players Systemic Antibiotics Product Solution and Service
3.7 Date of Enter into Systemic Antibiotics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Systemic Antibiotics Breakdown Data by Type
4.1 Global Systemic Antibiotics Historic Market Size by Type (2016-2021)
4.2 Global Systemic Antibiotics Forecasted Market Size by Type (2022-2027)

5 Systemic Antibiotics Breakdown Data by Application
5.1 Global Systemic Antibiotics Historic Market Size by Application (2016-2021)
5.2 Global Systemic Antibiotics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Systemic Antibiotics Market Size (2016-2027)
6.2 North America Systemic Antibiotics Market Size by Type
6.2.1 North America Systemic Antibiotics Market Size by Type (2016-2021)
6.2.2 North America Systemic Antibiotics Market Size by Type (2022-2027)
6.2.3 North America Systemic Antibiotics Market Size by Type (2016-2027)
6.3 North America Systemic Antibiotics Market Size by Application
6.3.1 North America Systemic Antibiotics Market Size by Application (2016-2021)
6.3.2 North America Systemic Antibiotics Market Size by Application (2022-2027)
6.3.3 North America Systemic Antibiotics Market Size by Application (2016-2027)
6.4 North America Systemic Antibiotics Market Size by Country
6.4.1 North America Systemic Antibiotics Market Size by Country (2016-2021)
6.4.2 North America Systemic Antibiotics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Systemic Antibiotics Market Size (2016-2027)
7.2 Europe Systemic Antibiotics Market Size by Type
7.2.1 Europe Systemic Antibiotics Market Size by Type (2016-2021)
7.2.2 Europe Systemic Antibiotics Market Size by Type (2022-2027)
7.2.3 Europe Systemic Antibiotics Market Size by Type (2016-2027)
7.3 Europe Systemic Antibiotics Market Size by Application
7.3.1 Europe Systemic Antibiotics Market Size by Application (2016-2021)
7.3.2 Europe Systemic Antibiotics Market Size by Application (2022-2027)
7.3.3 Europe Systemic Antibiotics Market Size by Application (2016-2027)
7.4 Europe Systemic Antibiotics Market Size by Country
7.4.1 Europe Systemic Antibiotics Market Size by Country (2016-2021)
7.4.2 Europe Systemic Antibiotics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Systemic Antibiotics Market Size (2016-2027)
8.2 Asia-Pacific Systemic Antibiotics Market Size by Type
8.2.1 Asia-Pacific Systemic Antibiotics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Systemic Antibiotics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Systemic Antibiotics Market Size by Type (2016-2027)
8.3 Asia-Pacific Systemic Antibiotics Market Size by Application
8.3.1 Asia-Pacific Systemic Antibiotics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Systemic Antibiotics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Systemic Antibiotics Market Size by Application (2016-2027)
8.4 Asia-Pacific Systemic Antibiotics Market Size by Region
8.4.1 Asia-Pacific Systemic Antibiotics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Systemic Antibiotics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Systemic Antibiotics Market Size (2016-2027)
9.2 Latin America Systemic Antibiotics Market Size by Type
9.2.1 Latin America Systemic Antibiotics Market Size by Type (2016-2021)
9.2.2 Latin America Systemic Antibiotics Market Size by Type (2022-2027)
9.2.3 Latin America Systemic Antibiotics Market Size by Type (2016-2027)
9.3 Latin America Systemic Antibiotics Market Size by Application
9.3.1 Latin America Systemic Antibiotics Market Size by Application (2016-2021)
9.3.2 Latin America Systemic Antibiotics Market Size by Application (2022-2027)
9.3.3 Latin America Systemic Antibiotics Market Size by Application (2016-2027)
9.4 Latin America Systemic Antibiotics Market Size by Country
9.4.1 Latin America Systemic Antibiotics Market Size by Country (2016-2021)
9.4.2 Latin America Systemic Antibiotics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Systemic Antibiotics Market Size (2016-2027)
10.2 Middle East & Africa Systemic Antibiotics Market Size by Type
10.2.1 Middle East & Africa Systemic Antibiotics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Systemic Antibiotics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Systemic Antibiotics Market Size by Type (2016-2027)
10.3 Middle East & Africa Systemic Antibiotics Market Size by Application
10.3.1 Middle East & Africa Systemic Antibiotics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Systemic Antibiotics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Systemic Antibiotics Market Size by Application (2016-2027)
10.4 Middle East & Africa Systemic Antibiotics Market Size by Country
10.4.1 Middle East & Africa Systemic Antibiotics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Systemic Antibiotics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Details
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Systemic Antibiotics Introduction
11.1.4 Bausch Health Revenue in Systemic Antibiotics Business (2016-2021)
11.1.5 Bausch Health Recent Development
11.2 Teva Pharmaceutical Industries
11.2.1 Teva Pharmaceutical Industries Company Details
11.2.2 Teva Pharmaceutical Industries Business Overview
11.2.3 Teva Pharmaceutical Industries Systemic Antibiotics Introduction
11.2.4 Teva Pharmaceutical Industries Revenue in Systemic Antibiotics Business (2016-2021)
11.2.5 Teva Pharmaceutical Industries Recent Development
11.3 Dr. Reddy’s Laboratories
11.3.1 Dr. Reddy’s Laboratories Company Details
11.3.2 Dr. Reddy’s Laboratories Business Overview
11.3.3 Dr. Reddy’s Laboratories Systemic Antibiotics Introduction
11.3.4 Dr. Reddy’s Laboratories Revenue in Systemic Antibiotics Business (2016-2021)
11.3.5 Dr. Reddy’s Laboratories Recent Development
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Details
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Systemic Antibiotics Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Systemic Antibiotics Business (2016-2021)
11.4.5 Sun Pharmaceutical Industries Recent Development
11.5 Amneal Pharmaceuticals
11.5.1 Amneal Pharmaceuticals Company Details
11.5.2 Amneal Pharmaceuticals Business Overview
11.5.3 Amneal Pharmaceuticals Systemic Antibiotics Introduction
11.5.4 Amneal Pharmaceuticals Revenue in Systemic Antibiotics Business (2016-2021)
11.5.5 Amneal Pharmaceuticals Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Systemic Antibiotics Introduction
11.6.4 Pfizer Revenue in Systemic Antibiotics Business (2016-2021)
11.6.5 Pfizer Recent Development
11.7 Mylan
11.7.1 Mylan Company Details
11.7.2 Mylan Business Overview
11.7.3 Mylan Systemic Antibiotics Introduction
11.7.4 Mylan Revenue in Systemic Antibiotics Business (2016-2021)
11.7.5 Mylan Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Systemic Antibiotics Introduction
11.8.4 Novartis Revenue in Systemic Antibiotics Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 Hikma Pharmaceuticals
11.9.1 Hikma Pharmaceuticals Company Details
11.9.2 Hikma Pharmaceuticals Business Overview
11.9.3 Hikma Pharmaceuticals Systemic Antibiotics Introduction
11.9.4 Hikma Pharmaceuticals Revenue in Systemic Antibiotics Business (2016-2021)
11.9.5 Hikma Pharmaceuticals Recent Development
11.10 Aurobindo Pharma
11.10.1 Aurobindo Pharma Company Details
11.10.2 Aurobindo Pharma Business Overview
11.10.3 Aurobindo Pharma Systemic Antibiotics Introduction
11.10.4 Aurobindo Pharma Revenue in Systemic Antibiotics Business (2016-2021)
11.10.5 Aurobindo Pharma Recent Development
11.11 Allergan
11.11.1 Allergan Company Details
11.11.2 Allergan Business Overview
11.11.3 Allergan Systemic Antibiotics Introduction
11.11.4 Allergan Revenue in Systemic Antibiotics Business (2016-2021)
11.11.5 Allergan Recent Development
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Company Details
11.12.2 GlaxoSmithKline Business Overview
11.12.3 GlaxoSmithKline Systemic Antibiotics Introduction
11.12.4 GlaxoSmithKline Revenue in Systemic Antibiotics Business (2016-2021)
11.12.5 GlaxoSmithKline Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Systemic Antibiotics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of β Lactam & β lactamase Inhibitors
Table 3. Key Players of Quinolone
Table 4. Key Players of Macrolide
Table 5. Key Players of Others
Table 6. Global Systemic Antibiotics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Systemic Antibiotics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Systemic Antibiotics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Systemic Antibiotics Market Share by Regions (2016-2021)
Table 10. Global Systemic Antibiotics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Systemic Antibiotics Market Share by Regions (2022-2027)
Table 12. Systemic Antibiotics Market Trends
Table 13. Systemic Antibiotics Market Drivers
Table 14. Systemic Antibiotics Market Challenges
Table 15. Systemic Antibiotics Market Restraints
Table 16. Global Systemic Antibiotics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Systemic Antibiotics Market Share by Players (2016-2021)
Table 18. Global Top Systemic Antibiotics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Antibiotics as of 2020)
Table 19. Ranking of Global Top Systemic Antibiotics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Systemic Antibiotics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Systemic Antibiotics Product Solution and Service
Table 23. Date of Enter into Systemic Antibiotics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Systemic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Systemic Antibiotics Revenue Market Share by Type (2016-2021)
Table 27. Global Systemic Antibiotics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Systemic Antibiotics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Systemic Antibiotics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Systemic Antibiotics Revenue Market Share by Application (2016-2021)
Table 31. Global Systemic Antibiotics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Systemic Antibiotics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Systemic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Systemic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Systemic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Systemic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Systemic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Systemic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Systemic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Systemic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Systemic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Systemic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Systemic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Systemic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Systemic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Systemic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Systemic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Systemic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Systemic Antibiotics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Systemic Antibiotics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Systemic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Systemic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Systemic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Systemic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Systemic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Systemic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Systemic Antibiotics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Systemic Antibiotics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Systemic Antibiotics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Systemic Antibiotics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Systemic Antibiotics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Systemic Antibiotics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Bausch Health Company Details
Table 64. Bausch Health Business Overview
Table 65. Bausch Health Systemic Antibiotics Product
Table 66. Bausch Health Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 67. Bausch Health Recent Development
Table 68. Teva Pharmaceutical Industries Company Details
Table 69. Teva Pharmaceutical Industries Business Overview
Table 70. Teva Pharmaceutical Industries Systemic Antibiotics Product
Table 71. Teva Pharmaceutical Industries Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 72. Teva Pharmaceutical Industries Recent Development
Table 73. Dr. Reddy's Laboratories Company Details
Table 74. Dr. Reddy's Laboratories Business Overview
Table 75. Dr. Reddy's Laboratories Systemic Antibiotics Product
Table 76. Dr. Reddy's Laboratories Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 77. Dr. Reddy's Laboratories Recent Development
Table 78. Sun Pharmaceutical Industries Company Details
Table 79. Sun Pharmaceutical Industries Business Overview
Table 80. Sun Pharmaceutical Industries Systemic Antibiotics Product
Table 81. Sun Pharmaceutical Industries Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 82. Sun Pharmaceutical Industries Recent Development
Table 83. Amneal Pharmaceuticals Company Details
Table 84. Amneal Pharmaceuticals Business Overview
Table 85. Amneal Pharmaceuticals Systemic Antibiotics Product
Table 86. Amneal Pharmaceuticals Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 87. Amneal Pharmaceuticals Recent Development
Table 88. Pfizer Company Details
Table 89. Pfizer Business Overview
Table 90. Pfizer Systemic Antibiotics Product
Table 91. Pfizer Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Mylan Company Details
Table 94. Mylan Business Overview
Table 95. Mylan Systemic Antibiotics Product
Table 96. Mylan Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 97. Mylan Recent Development
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 101. Novartis Recent Development
Table 102. Hikma Pharmaceuticals Company Details
Table 103. Hikma Pharmaceuticals Business Overview
Table 104. Hikma Pharmaceuticals Systemic Antibiotics Product
Table 105. Hikma Pharmaceuticals Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 106. Hikma Pharmaceuticals Recent Development
Table 107. Aurobindo Pharma Company Details
Table 108. Aurobindo Pharma Business Overview
Table 109. Aurobindo Pharma Systemic Antibiotics Product
Table 110. Aurobindo Pharma Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 111. Aurobindo Pharma Recent Development
Table 112. Allergan Company Details
Table 113. Allergan Business Overview
Table 114. Allergan Systemic Antibiotics Product
Table 115. Allergan Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 116. Allergan Recent Development
Table 117. GlaxoSmithKline Company Details
Table 118. GlaxoSmithKline Business Overview
Table 119. GlaxoSmithKline Systemic Antibiotics Product
Table 120. GlaxoSmithKline Revenue in Systemic Antibiotics Business (2016-2021) & (US$ Million)
Table 121. GlaxoSmithKline Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Antibiotics Market Share by Type: 2020 VS 2027
Figure 2. β Lactam & β lactamase Inhibitors Features
Figure 3. Quinolone Features
Figure 4. Macrolide Features
Figure 5. Others Features
Figure 6. Global Systemic Antibiotics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Specialty Clinic Case Studies
Figure 9. Homecare Case Studies
Figure 10. Others Case Studies
Figure 11. Systemic Antibiotics Report Years Considered
Figure 12. Global Systemic Antibiotics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Systemic Antibiotics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Systemic Antibiotics Market Share by Regions: 2020 VS 2027
Figure 15. Global Systemic Antibiotics Market Share by Regions (2022-2027)
Figure 16. Global Systemic Antibiotics Market Share by Players in 2020
Figure 17. Global Top Systemic Antibiotics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Antibiotics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Systemic Antibiotics Revenue in 2020
Figure 19. Global Systemic Antibiotics Revenue Market Share by Type (2016-2021)
Figure 20. Global Systemic Antibiotics Revenue Market Share by Type (2022-2027)
Figure 21. North America Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Systemic Antibiotics Market Share by Type (2016-2027)
Figure 23. North America Systemic Antibiotics Market Share by Application (2016-2027)
Figure 24. North America Systemic Antibiotics Market Share by Country (2016-2027)
Figure 25. United States Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Systemic Antibiotics Market Share by Type (2016-2027)
Figure 29. Europe Systemic Antibiotics Market Share by Application (2016-2027)
Figure 30. Europe Systemic Antibiotics Market Share by Country (2016-2027)
Figure 31. Germany Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Systemic Antibiotics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Systemic Antibiotics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Systemic Antibiotics Market Share by Region (2016-2027)
Figure 41. China Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Systemic Antibiotics Market Share by Type (2016-2027)
Figure 49. Latin America Systemic Antibiotics Market Share by Application (2016-2027)
Figure 50. Latin America Systemic Antibiotics Market Share by Country (2016-2027)
Figure 51. Mexico Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Systemic Antibiotics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Systemic Antibiotics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Systemic Antibiotics Market Share by Country (2016-2027)
Figure 57. Turkey Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Systemic Antibiotics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Bausch Health Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 61. Teva Pharmaceutical Industries Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 62. Dr. Reddy's Laboratories Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 63. Sun Pharmaceutical Industries Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 64. Amneal Pharmaceuticals Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 66. Mylan Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 67. Novartis Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 68. Hikma Pharmaceuticals Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 69. Aurobindo Pharma Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 70. Allergan Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 71. GlaxoSmithKline Revenue Growth Rate in Systemic Antibiotics Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed